[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335029-105":3,"doc-detail-335029-en":81,"detail-sidebar-cat-0-en-105":98},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","trained-immunity-inducers-in-cancer-immunotherapy-review","Trained immunity inducers in cancer immunotherapy - Review","","Reviewing how trained immunity inducers can improve cancer outcomes, the article explains that many cancer immunotherapies mainly rely on adaptive immunity, yet limited responder fractions and severe adverse effects restrict broader use. Trained immunity is framed as innate immune memory capable of antigen-independent, long-term enhanced function. BCG and fungal glucan are highlighted for reversing suppressive tumor microenvironments, boosting T-cell responses, and enabling tumor regression. Mechanistic induction pathways, preclinical/clinical evidence, and future challenges are summarized.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/trained-immunity-inducers-in-cancer-immunotherapy-review/335029/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/trained-immunity-inducers-in-cancer-immunotherapy-review/335029.png","ImageObject",300,407,{"name":42,"@type":43},"Noah","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is trained immunity and how is it different from classical adaptive immunity?","Question",{"text":63,"@type":64},"Trained immunity, or trained innate immunity, describes innate cells that acquire enhanced long-term functionality resembling immune memory. Unlike adaptive responses, it is antigen non-specific and can be triggered by stimuli such as BCG or fungal glucan.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How can trained immunity inducers contribute to cancer immunotherapy?",{"text":68,"@type":64},"Trained immunity inducers are used in cancer patients to elicit immune responses that can kill tumor cells. The approach expands the responding repertoire by involving innate and non-immune cell types and can reshape anti-cancer immunity alongside adaptive responses.",{"name":70,"@type":61,"acceptedAnswer":71},"Which mechanisms and factors are emphasized as critical for trained immunity induction in cancer contexts?",{"text":72,"@type":64},"The review highlights critical roles of emergency granulopoiesis, interferon g (γ), and tissue-specific induction. It also summarizes how induction is established through transcriptomic, metabolic, and epigenetic programming.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335029,1790877425,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":86,"file_id":87,"file_url":88,"file_type":89,"file_size":90,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":91,"language":92,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":93,"faqs":94,"seo_title":95,"seo_description":12,"update_tm":96,"read_time":97,"preview_page_count":4},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","TYPE Review  \nPUBLISHED 16 July 2024  \nDOI 10.3389/fimmu.2024.1427443  \nOPEN ACCESS  \nEDITED BY  \nJorge Contreras-Garduño,  \nNational Autonomous University of Mexico, Mexico  \nREVIEWED BY  \nJoel E. Lopez-Meza,  \nMichoacana University of San Nicol´as de Hidalgo, Mexico  \nHumberto Lanz-Mendoza,  \nNational Institute of Public Health, Mexico  \n*CORRESPONDENCE Yongjun Sui  \n [suiy@mail.nih.gov](suiy@mail.nih.gov)  \nRECEIVED 03 May 2024  \nACCEPTED 28 June 2024  \nPUBLISHED 16 July 2024  \nCITATION  \nSui Y and Berzofsky JA (2024) Trained immunity inducers in cancer immunotherapy. Front. Immunol. 15:1427443 .  \ndoi: 10.3389/fimmu.2024.1427443  \nCOPYRIGHT  \n© 2024 Sui and Berzofsky. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTrained immunity inducers in cancer immunotherapy  \nYongjun Sui* and Jay A. Berzofsky  \nVaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, United States  \nWhile most of the cancer immunotherapy strategies engage adaptive immunity, especially tumor-associated T cells, the small fraction of responding patients and types of cancers amenable, and the possibility of severe adverse effects limit its usage. More effective and general interventions are urgently needed. Recently, ade facto innate immune memory, termed ‘trained immunity ’, has become a new research focal point, and promises to be a powerful tool for achieving long-term therapeutic beneﬁts against cancers. Trained immunity-inducing agents such as BCG and fungal glucan have been shown to be able to avert the suppressive tumor microenvironment (TME), enhance T cell responses, and eventually lead to tumor regression. Here, we review the current understating of trained immunity induction and highlight the critical roles of emergency granulopoiesis, interferon g and tissue-speciﬁc induction. Preclinical and clinical studies that have exploited trained immunity inducers for cancer immunotherapy are summarized, and repurposed trained immunity inducers from other ﬁelds are proposed. We also outline the challenges and opportunities for trained immunity in future cancer immunotherapies. We envisage that more effective cancer vaccines will combine the induction of trained immunity with T cell therapies.  \nKEYWORDS  \ntrained immunity, cancer immunotherapy, tumor microenvironment, T cell responses, interferon g  \n1 Introduction  \nTrained immunity, also called trained innate immunity, is an emerging concept that innate cells harbor features of immunological memory and display enhanced long-term functionality (1–3) . In the past decade, both myeloid (monocytes, macrophages and dendritic cells) and lymphoid (natural killer cells and innate lymphoid cells) cells of the innate immune system, as well as non-immune cells (epithelial, stromal cells, ﬁbroblastsand muscle cells) have been shown to display long-term memory upon stimulation (4, 5) . Trained immunity bridges innate and adaptive immunity. Its two main features are its antigen non-speciﬁc manner and long-term memory. The deﬁnition and key features of trained immunity in health and disease has been discussed in reference 3. As suggested by its name, trained innate immunity is mediated by innate cells. Given the fact that innate cells lack antigen-speciﬁc immune responses, one hallmark of trained immunity is that it  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nacts in an antigen-independent manner, i.e., it can be evoked by one stimulus and protect the host against a wide range of insults in addition to the original one that induced ","cbCail0Go5HaRQN1","https://ap.wps.com/l/cbCail0Go5HaRQN1","pdf",1391960,11,"English","# Introduction\n# Mechanisms of trained immunity induction and maintenance","[{\"question\":\"What is trained immunity and how is it different from classical adaptive immunity?\",\"answer\":\"Trained immunity, or trained innate immunity, describes innate cells that acquire enhanced long-term functionality resembling immune memory. Unlike adaptive responses, it is antigen non-specific and can be triggered by stimuli such as BCG or fungal glucan.\"},{\"question\":\"How can trained immunity inducers contribute to cancer immunotherapy?\",\"answer\":\"Trained immunity inducers are used in cancer patients to elicit immune responses that can kill tumor cells. The approach expands the responding repertoire by involving innate and non-immune cell types and can reshape anti-cancer immunity alongside adaptive responses.\"},{\"question\":\"Which mechanisms and factors are emphasized as critical for trained immunity induction in cancer contexts?\",\"answer\":\"The review highlights critical roles of emergency granulopoiesis, interferon g (γ), and tissue-specific induction. It also summarizes how induction is established through transcriptomic, metabolic, and epigenetic programming.\"}]","Trained immunity inducers in cancer immunotherapy - Review | PDF",1790009338,28,{"code":4,"msg":82,"data":99},[100,104,108,112,117,122,127,130,135,138,142],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":101,"show_sort_weight":102,"slug":103},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":105,"show_sort_weight":106,"slug":107},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":109,"show_sort_weight":110,"slug":111},"Exam",70,"exam",{"id":113,"doc_module":4,"doc_module_name":25,"category_name":114,"show_sort_weight":115,"slug":116},5,"Comic",60,"comic",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},6,"Technology",50,"technology",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":125,"slug":126},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":128,"slug":129},30,"research-report",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},9,"Religion & Spirituality",20,"religion-spirituality",{"id":133,"doc_module":4,"doc_module_name":25,"category_name":136,"show_sort_weight":133,"slug":137},"World Cup","world-cup",{"id":139,"doc_module":4,"doc_module_name":25,"category_name":140,"show_sort_weight":139,"slug":141},10,"Lifestyle","lifestyle",{"id":143,"doc_module":4,"doc_module_name":25,"category_name":144,"show_sort_weight":113,"slug":145},19,"General","general"]